GoodRx – for $$$ savings on prescriptions

To get the information, GoodRx partners with pharmacy chains such as CVS, Target, Walgreens, Kroger and Walmart; pharmacy benefits managers (PBMs) such as Express Scripts and Caremark; and pharmaceutical companies. Individuals can now get real-time prices at 70,000 locations nationwide.

The company, which ranks No. 6 on the 2019 CNBC Disruptor 50 list, says consumers can save up to 80% with its free GoodRx Pharmacy Discount Cards, as well as through coupons on its site. The company claims that it’s helped Americans save $10 billion on prescriptions since launching in 2011.An industry cloaked in secrecy

As it turns out, Hirsch’s experience is pretty standard. Most Americans don’t know that prices can vary wildly from pharmacy to pharmacy.

“Most Americans are buying blind. They don’t know how much a drug is going to cost when they get a prescription … and they don’t know that they might be able to get it for less if they just pay cash or walk into another pharmacy,” said Robin Feldman, a law professor with a focus on intellectual property and antitrust at UC Hastings College of Law and author of “Drugs, Money, and Secret Handshakes.”

This is becoming an increasingly critical issue as drug prices in the U.S. spiral out of control. Even after rebates, Medicare spending for brand-name drugs rose 62% between 2011 and 2015, says Feldman. The prices of the 20 most commonly prescribed brand-name drugs for seniors have risen nearly 10 times more than the annual rate of inflation over the past five years, according to a congressional report released earlier this month.

Prices are continuing to rise. According to a quarterly report from GoodRx, the average list price of drugs — that’s the price set by the manufacturer — rose 2.9% in the first quarter ending March 31, 2019.

Rising drug prices have many patients and doctors very concerned. The consequences are alarming. And bad for everyone.

“Americans are struggling to pay for prescription drugs which have huge consequences for their health. Numerous studies have found people delayed treatment, split pills, or rationed medication because of the extreme costs that we experience in the United States. The high prices hit people in the pocketbook. They also affect their health,” said Adam Garber of U.S. PIRG, a public interest advocacy group that recently released a report on spiraling medication costs.

Prescription costs are affected by a web of factors. Pharmaceutical companies sell medicine to consumers via PBMs, which then deal with insurance companies and pharmacies, using tactics such as discounts and rebates to set prices. The agreements at every step along the way are confidential, hidden not only from consumers but also from lawmakers. Not only that, but various forces channel patients into more expensive drugs. As a result of these agreements, prices can vary wildly from pharmacy to pharmacy.

GoodRx founders and co-CEOs: Doug Hirsch (left) and Trevor Bezdek

Against this muddled backdrop, GoodRx helps patients by shining a spotlight on drug prices and how much they can vary. The site shows the price for various medications, easily searchable by name, and makes it easy to pull up coupons from manufacturers, GoodRx and pharmacies. GoodRx also has a monthly subscription program, GoodRx Gold, which offers additional discounts.Americans are struggling to pay for prescription drugs which have huge consequences for their health.

But the site only has access to information on how much patients would pay without insurance. Pricing agreements between insurance companies and pharmacies are not available, and patients generally cannot get that information until they get to the pharmacy counter.

Companies like GoodRx are “adding some transparency, but I think ultimately we need to restructure how prescription drug prices are set — to look at the value consumers are receiving and making sure that our dollars are making us healthy at a reasonable cost,” said Garber.Drug prices are in the regulatory spotlight

High drug prices are getting more attention these days with lawmakers and advocacy groups pushing for changes that can lower drug prices and increase transparency.

There are now various bills pushing for more transparency around health-care costs, including prescription drugs, at the federal level and in most states. There’s discussion on both the state and federal level about creating expert review boards to examine pricing and evaluate ways to reduce prices or focus on price gouging by requiring companies to justify huge price increases.

“The thing that I think is most interesting on the transparency side is that you’re seeing policies like it move at the state level in red and blue states,” said Garber. “Everyone knows someone with a prescription drug problem or has had to deal with this and felt the frustration,” he added.

The pharmaceutical industry, which says pricing information is a trade secret that should not be revealed, is fighting these transparency efforts through the legislatures and various lawsuits.

“Well-functioning markets don’t operate in a shroud of secrecy. I like to say that markets, like gardens, grow best in the sun and they wither without information. An industry full of secret deals and secret handshakes is unlikely to be good for consumers,” said Feldman.

There is plenty of room for improvement, starting with more transparency.

“We have a long way to go. Over 200 million prescriptions are left at the counter each year. These are prescriptions that are fulfilled, and then people walk away. That is a travesty that people walk away because they can’t afford them,” said Hirsch.

He adds: “Ultimately I’d like to see our nation provide quality, affordable health care to everyone. It seems unlikely that we’ll replace our current system anytime soon, and it’s worth noting that existing government-administered programs — Medicare and Medicaid — contain significant gaps.

“Canada provides single-payer health care, and yet market forces actually make many generic medications cheaper in the U.S. If all medications and health care were free, we’d be happy to move on to some other challenge, but sadly I think that remains out of reach for the moment,” says Hirsch.